Vantage-Consulting-Group

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ADCT",
  "BW",
  "FGEN",
  "CBUS"
]

13F-HR • 2025-03-31

Data Enrichment

100% identified

4 identified0 unidentified

Holdings

Manager:

4 positions • $5.0M total value

Manager:

Search and click to pin securities to the top

Sort by:

Cibus, Inc.

Shares:1.1M

Value:$2.1M

% of Portfolio:42.6% ($2.1M/$5.0M)

Babcock & Wilcox Enterprises, Inc.

Shares:2.4M

Value:$1.6M

% of Portfolio:32.3% ($1.6M/$5.0M)

ADC Therapeutics SA

Shares:850.7K

Value:$1.2M

% of Portfolio:23.9% ($1.2M/$5.0M)

FIBROGEN INC

Shares:195.7K

Value:$60.6K

% of Portfolio:1.2% ($60.6K/$5.0M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Cibus, Inc.(CBUScusip17166A101)	1.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.1M	42.6% ($2.1M/$5.0M)	QoQ -32.73% (-$1.0M) YoY -91.67% (-$23.6M)
Babcock & Wilcox Enterprises, Inc.(BWcusip05614L209)	2.4M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.6M	32.3% ($1.6M/$5.0M)	QoQ -58.99% (-$2.3M) YoY -40.49% (-$1.1M)
ADC Therapeutics SA(ADCTcusipH0036K147)	850.7K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.2M	23.9% ($1.2M/$5.0M)	QoQ -29.14% (-$493.4K) YoY -68.59% (-$2.6M)
FIBROGEN INC(FGENcusip31572Q808)	195.7K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$60.6K	1.2% ($60.6K/$5.0M)	QoQ -41.47% (-$43.0K) YoY -86.81% (-$399.3K)